Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Resubmission Acknowledgment Letter, July 30, 2012 - Flublok

DEPARTMENT OF HEALTH & HUMAN SERVICES                                                     Public Health Service

                                                                                                                            Food and Drug Administration
Rockville, MD 20852-1448


Our STN: BL 125285/0
Protein Sciences Corporation
Attention: Penny L. Post, Ph.D.
1000 Research Parkway
Meriden, CT 06450-7159
Dear Dr. Post:
We have received your July 16, 2012, resubmission to your biologics license application for Influenza Vaccine, for the active immunization of adults 18 years of age and older against influenza disease on July 17, 2012.
We consider this a complete, Class 2 response to our action letter. Therefore, the user fee goal date is January 16, 2013.
If you have any questions, please contact the Regulatory Project Manager, Dr. Timothy Fritz, at (301) 796-2640.
Sincerely yours,
 Wellington Sun, M.D.
 Division of Vaccines and
   Related Products Applications
 Office of Vaccines
  Research and Review
Center for Biologics
  Evaluation and Research

Page Last Updated: 02/15/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English